Skip to main content
Howard Dittrich, MD, Cardiology, San Diego, CA

HowardDittrichMD

Cardiology San Diego, CA

Physician

Dr. Dittrich is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Dittrich's full profile

Already have an account?

  • Office

    200 W Arbor Dr
    San Diego, CA 92103
    Phone+1 858-657-8530

Education & Training

  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterFellowship, Cardiovascular Disease, 1982 - 1984
  • University of California (San Diego) Medical Center
    University of California (San Diego) Medical CenterResidency, Internal Medicine, 1978 - 1981
  • University of Iowa Roy J. and Lucille A. Carver College of Medicine
    University of Iowa Roy J. and Lucille A. Carver College of MedicineClass of 1978

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • CA State Medical License
    CA State Medical License 1979 - 2019
  • NV State Medical License
    NV State Medical License 1981 - 2013
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Authored Content

  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018
  • Prevalence, Predictors and Clinical Outcome of Residual Congestion in Acute Decompensated Heart FailureMarch 2018

Press Mentions

  • Cirius Therapeutics Announces Results from Phase 2b NASH Study Supporting Advancing to Phase 3 Development of MSDC-0602K; Data Accepted for Late Breaker Presentation at the Liver Meeting
    Cirius Therapeutics Announces Results from Phase 2b NASH Study Supporting Advancing to Phase 3 Development of MSDC-0602K; Data Accepted for Late Breaker Presentation at the Liver MeetingNovember 8th, 2019
  • Cirius Therapeutics Expands Scientific Advisory Board
    Cirius Therapeutics Expands Scientific Advisory BoardJune 12th, 2019

Professional Memberships